Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001240591 | SCV001413554 | pathogenic | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr245*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with retinal disease (PMID: 19074458, 23755871). ClinVar contains an entry for this variant (Variation ID: 966011). For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Molecular Genetics, |
RCV001352995 | SCV001548087 | likely pathogenic | Cone-rod dystrophy 3 | 2021-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001240591 | SCV002817964 | pathogenic | not provided | 2022-06-27 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29099798, 25525159, 33546218, 34945039, 23755871, 32244552, 19074458, 21911583, 15192030, 28947085) |
Ophthalmo- |
RCV004557479 | SCV005046930 | pathogenic | Stargardt disease 3 | no assertion criteria provided | research |